Taxanes in the Treatment of Advanced Gastric Cancer

被引：16
|
作者：
Kang, Byung Woog [1 ]
Kwon, Oh-Kyoung [2 ]
Chung, Ho Young [2 ]
Yu, Wansik [2 ]
Kim, Jong Gwang [1 ]
机构：
[1] Kyungpook Natl Univ, Dept Oncol Hematol, Med Ctr, Sch Med,Canc Res Inst, 807 Hogukno, Daegu 41404, South Korea
[2] Kyungpook Natl Univ, Dept Surg, Kyungpook Natl Univ Hosp, Sch Med, Daegu 41494, South Korea
来源：
MOLECULES | 2016年 / 21卷 / 05期
基金：
新加坡国家研究基金会;
关键词：
gastric cancer; taxanes; paclitaxel; docetaxel; chemotherapy; PHASE-III TRIAL; ALBUMIN-BOUND PACLITAXEL; 2ND-LINE CHEMOTHERAPY; 1ST-LINE THERAPY; PLUS CISPLATIN; ANTITUMOR-ACTIVITY; OPEN-LABEL; FLUOROURACIL; DOCETAXEL; ADENOCARCINOMA;
D O I：
10.3390/molecules21050651
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Although rapid advances in treatment options have improved the prognosis of advanced gastric cancer (AGC), it remains a major public health problem and the second leading cause of cancer-related deaths in the world. Taxanes (paclitaxel and docetaxel) are microtubule stabilizing agents that inhibit the process of cell division, and have shown antitumor activity in the treatment of AGC as a single or combination chemotherapy. Accordingly, this review focuses on the efficacy and tolerability of taxanes in the first-or second-line chemotherapy setting for AGC.
引用
收藏
页数：10
相关论文
共 50 条
  • [41] The role of taxanes in the treatment of breast cancer
    Capri, G
    Tarenzi, E
    Fulfaro, F
    Gianni, L
    SEMINARS IN ONCOLOGY, 1996, 23 (01) : 68 - 75
  • [42] Taxanes in the treatment of early breast cancer
    Ring, AE
    Ellis, PA
    CANCER TREATMENT REVIEWS, 2005, 31 (08) : 618 - 627
  • [43] The role of taxanes in breast cancer treatment
    Levin, M
    DRUGS OF TODAY, 2001, 37 (01) : 57 - 65
  • [44] The role of taxanes in the treatment of breast cancer
    Nabholtz, JM
    Gligorov, J
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (07) : 1073 - 1094
  • [45] Taxanes in the treatment of head and neck cancer
    Schrijvers, D
    Vermorken, JB
    CURRENT OPINION IN ONCOLOGY, 2005, 17 (03) : 218 - 224
  • [46] TREATMENT OUTCOME OF ADVANCED GASTRIC CANCER WITH DOUBLE PRIMARY CANCER
    Yamaguchi, Shigeo
    Shimoyama, Tatsu
    Kanamasa, Yusuke
    Sasaki, Eisaku
    Omuro, Yasushi
    Maeda, Yoshiharu
    Sasaki, Tsuneo
    ANNALS OF ONCOLOGY, 2014, 25
  • [47] Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer
    Kohei Shitara
    Keitaro Matsuo
    Ayako Mizota
    Chihiro Kondo
    Motoo Nomura
    Daisuke Takahari
    Tomoya Yokota
    Takashi Ura
    Seiji Ito
    Akira Sawaki
    Masahiro Tajika
    Hiroki Kawai
    Kei Muro
    Gastric Cancer, 2011, 14 : 155 - 160
  • [48] Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer
    Shitara, Kohei
    Matsuo, Keitaro
    Mizota, Ayako
    Kondo, Chihiro
    Nomura, Motoo
    Takahari, Daisuke
    Yokota, Tomoya
    Ura, Takashi
    Ito, Seiji
    Sawaki, Akira
    Tajika, Masahiro
    Kawai, Hiroki
    Muro, Kei
    GASTRIC CANCER, 2011, 14 (02) : 155 - 160
  • [49] Second line treatment with Camptothecins and Taxanes in advanced non-small cell lung cancer
    Kakolyris, S
    Georgoulias, V
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 183 - 189
  • [50] Treatment of locally advanced gastric cancer with preoperative chemotherapy
    Izhanov, E.
    Arzykulov, Z.
    ANNALS OF ONCOLOGY, 2007, 18 : VII93 - VII93
12345